Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
PaperCitations, authors & open-access status
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 300 citations, 2016 year and closed oa status.
300
Citations
2016
Year
closed
OA Status